International Programs News, Speeches, and Publications
Image
Connect with us: Follow @FDA_Global on Twitter
FDA International News
- FDA Announces Withdrawal from Global Harmonization Working Party, CDRH Statement, November 27, 2023
- FDA Officials Meet with South African Health Products Regulatory Authority Delegation, OGPS Statement, August 29, 2023
- FDA Signs Shrimp Regulatory Partnership Agreement with Ecuador, OGPS Statement, August 25, 2023
- FDA Mutual Recognition Agreement with Swissmedic Enters Into Force, OGPS Statement, July 27, 2023
- FDA Signs Confidentially Commitment with Indonesia, OGPS Statement, July 10, 2023
- U.S. and India Cooperate on “Operation Broader Sword” to Stop International Shipments of Illegal and Dangerous Drugs, U.S. Embassy & Consulates in India Press Release, July 7, 2023
- FDA Expands Mutual Recognition Agreement with European Union, OGPS Statement, May 31, 2023
- Japanese Officials Meet with FDA to Discuss Future Collaborations, OGPS Statement, May 9, 2023
- Xinjiang Uyghur Autonomous Region of the People's Republic China, OGPS Statement, April 12, 2023
- FDA Officials Meet with Delegation from Nigeria, OGPS Statement, April 4, 2023
- FDA Officials Meet with Representatives of Mexico’s National Service of Agro-Alimentary Health, Safety and Quality (SENASICA), OGPS Statement, March 28, 2023 [Spanish translation]
- South Korean Health Officials Meet with FDA to Discuss Future Collaborations, OGPS Statement, March 21, 2023
- Danish Minister of Health and Danish Medicines Agency Meet with FDA to Discuss Future Collaborations, OGPS Statement, March 10, 2023
- FDA Agreement on Mutual Recognition between the Swiss Confederation and the United States of America Relating to Pharmaceutical Good Manufacturing Practice, OGPS Statement, January 12, 2023
- OGPS Leadership Message on Local Employed Staff Appreciation Day, OGPS Statement, November 16, 2022
- FDA Signs Confidentiality Commitment with Ecuador, OGPS Statement, August 18, 2022 [Spanish translation]
- FDA Meets with European Food and Drug Regulators, OGPS Statement, July 8, 2022
- Brazilian Health Regulatory Agency Meets with FDA to Discuss Medical Product Issues, OGPS Statement, May 18, 2022
- Meeting of Officials of the U.S. Food and Drug Administration and the German Federal Institute for Risk Assessment, OGPS Statement, May 9, 2022
U.S. Government Documents of International Interest
- Joint Update by the Department of State and the Department of Health and Human Services on Negotiations Toward a Pandemic Accord
- Letter Exchange Involving Aspartame
International Partner News
- WHO calls on countries to increase taxes on alcohol and sugary sweetened beverages, Pan American Health Organization, Press Release, December 2023
- Global regulators strengthen efforts to ensure continuous availability of safe and high-quality medicines, European Medicines Agency, Press Release, December 2023
- APEC Advances Indigenous Peoples’ Economic Priorities through Trade, Asia-Pacific Economic Cooperation, Press Release, December 2023
- WHO calls on governments for urgent action to invest in Universal Health Coverage, World Health Organization, Press Release, December 2023
- Global regulators celebrate 10 years of strategic leadership and cooperation, European Medicines Agency, Press Release, November 2023
- PAHO Director underscores transatlantic partnerships to address present and future health challenges, Pan American Health Organization, Press Release, October 2023
- Germany gives EUR 500,000 to enhance developing economies’ trading skills, World Trade Organization, Press Release, October 2023
- APEC Makes Progress on Structural Reform Amid Challenges, Asia Pacific Economic Cooperation, Press Release, October 2023
- EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens, European Medicines Agency, Press Release, October 2023
Speeches
- Remarks by Deputy Commissioner for Policy, Legislation, and International Affairs Andi Fristedt at Peking University, Beijing, China, June 14, 2023
- Remarks by Associate Commissioner Mark Abdoo at the International Bar Association World Life Sciences Conference, June 1, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Food & Drug Law Institute 2023 Conference, May 18, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Asia-Pacific Economic Cooperation Medical Product Supply Chain Dialogue, April 25, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Indian Society for Clinical Research 16th Annual Meeting, February 24, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Parenteral Drug Association India Chapter 10th Annual Meeting, February 21, 2023
Publications
Blog
- From a Global Perspective - Occasional thought pieces on international topics from FDA experts across the agency
Newsletter
- Global Update – Global news, information, events, and resources from the FDA Office of Global Policy and Strategy
FDA Voices
- Using A Whole-Of-Governments Approach to Combating Illicit Health Products, FDA Voices, September 1, 2022
- Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines, FDA Voices, July 19, 2021
- FDA’s Partnership with Mexico’s Regulators Strengthens Food Safety Protections, FDA Voices, March 17, 2021
- Equivalence: Using a Trade Mechanism to Ensure Broader Consumer Choice and Open New Markets for Molluscan Shellfish, FDA Voices, September 23, 2020
- Ensuring Patient Safety and Drug Manufacturing Quality Through Partnership with European Union Regulators, FDA Voices, by Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, FDA’s Associate Commissioner for the Office of Global Policy and Strategy, FDA Voices, July 11, 2019
- FDA’s Global Efforts to Protect Patients and Consumers from Unsafe Products, FDA Voices, by Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, FDA’s Associate Commissioner for the Office of Global Policy and Strategy, FDA Voices, November 29, 2018
- FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India, FDA Voices, July 12, 2017
- FDA in India: Championing a Culture of Quality, FDA Voices, March 28, 2017